| Website | labnow.com/overvi... |
| Category | BioTech |
| Phone | 512.329.9998 |
| info@labnow.com | |
| Employees | |
| Description | Point-of-care Diagnostics |
| TOTAL | $34M |
| FUNDING TOTAL | $34M |
| Series A, 9/04 George Soros Austin Ventures | $14M |
| Series B, 11/07 Sammons Enterprises Austin Ventures | $20M |
| DEBT TOTAL | $500k |
| Debt, 11/09 | $500k |
LabNow, Inc. is a company specializing in point-of-care diagnostic. It uses a lab-on-a-chip sensor technology that is capable of automating complex fluid analysis quickly, easily, and accurately.
This technology converges the main advances in nanochemistry, microfluids, imaging analysis, and digital fluorescence microscopy. Certain specific functions will soon be applied to HIV/AIDS care and other pertinent diseases.
